185 related articles for article (PubMed ID: 28057404)
1. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
Dean JA; Welsh LC; Wong KH; Aleksic A; Dunne E; Islam MR; Patel A; Patel P; Petkar I; Phillips I; Sham J; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):263-273. PubMed ID: 28057404
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
Dean JA; Wong KH; Welsh LC; Jones AB; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
Radiother Oncol; 2016 Jul; 120(1):21-7. PubMed ID: 27240717
[TBL] [Abstract][Full Text] [Related]
3. Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk.
Dean JA; Welsh LC; McQuaid D; Wong KH; Aleksic A; Dunne E; Islam MR; Patel A; Patel P; Petkar I; Phillips I; Sham J; Newbold KL; Bhide SA; Harrington KJ; Gulliford SL; Nutting CM
Radiother Oncol; 2016 Apr; 119(1):166-71. PubMed ID: 26970676
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
5. Impact of delineation errors on the estimated organ at risk dose and of dose errors on the normal tissue complication probability model.
Mövik L; Bäck A; Pettersson N
Med Phys; 2023 Mar; 50(3):1879-1892. PubMed ID: 36693127
[TBL] [Abstract][Full Text] [Related]
6. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
Deneuve S; Bastogne T; Duclos M; Mirjolet C; Bois P; Bachmann P; Nokovitch L; Roux PE; Girodet D; Poupart M; Zrounba P; Claude L; Ferella L; Iacovelli NA; Foray N; Rancati T; Pereira S
Tumori; 2023 Apr; 109(2):173-185. PubMed ID: 35578746
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors.
Musha A; Shimada H; Shirai K; Saitoh J; Yokoo S; Chikamatsu K; Ohno T; Nakano T
PLoS One; 2015; 10(10):e0141734. PubMed ID: 26512725
[TBL] [Abstract][Full Text] [Related]
8. Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.
Dean JA; Wong KH; Gay H; Welsh LC; Jones AB; Schick U; Oh JH; Apte A; Newbold KL; Bhide SA; Harrington KJ; Deasy JO; Nutting CM; Gulliford SL
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):820-831. PubMed ID: 27788955
[TBL] [Abstract][Full Text] [Related]
9. A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules.
Strigari L; Pedicini P; D'Andrea M; Pinnarò P; Marucci L; Giordano C; Benassi M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e697-702. PubMed ID: 22578541
[TBL] [Abstract][Full Text] [Related]
10. A data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patients.
Robertson SP; Quon H; Kiess AP; Moore JA; Yang W; Cheng Z; Afonso S; Allen M; Richardson M; Choflet A; Sharabi A; McNutt TR
Med Phys; 2015 Jul; 42(7):4329-37. PubMed ID: 26133630
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
Kanehira T; van Kranen S; Jansen T; Hamming-Vrieze O; Al-Mamgani A; Sonke JJ
Radiother Oncol; 2021 Nov; 164():209-215. PubMed ID: 34619234
[TBL] [Abstract][Full Text] [Related]
12. Delineation of Oral Mucosa as a Pseudo-Organ-at-Risk May Lead to a Decrease in the Incidence of Oral Mucositis: A Dosimetric Analysis of Intensity-Modulated Radiation Therapy Plans in Head and Neck Cancers.
Khattar H; Kumar P; S N
Cureus; 2022 Mar; 14(3):e23716. PubMed ID: 35505730
[TBL] [Abstract][Full Text] [Related]
13. Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit.
Nangia S; Gaikwad U; Noufal MP; Sawant M; Wakde M; Mathew A; Chilukuri S; Sharma D; Jalali R
Radiat Oncol; 2023 Jul; 18(1):121. PubMed ID: 37468950
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
[TBL] [Abstract][Full Text] [Related]
15. Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.
Dean J; Wong K; Gay H; Welsh L; Jones AB; Schick U; Oh JH; Apte A; Newbold K; Bhide S; Harrington K; Deasy J; Nutting C; Gulliford S
Clin Transl Radiat Oncol; 2018 Jan; 8():27-39. PubMed ID: 29399642
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological modeling of radiation-induced acute mucosal toxicity (oral mucositis and pharyngeal mucositis): A single-institutional study of head-and-neck carcinoma.
Singh B; Singh G; Oinam AS; Kumar V; Vashistha R; Sidhu MS; Singh M
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0-S1715. PubMed ID: 37147947
[TBL] [Abstract][Full Text] [Related]
17. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.
Stokman MA; Spijkervet FK; Burlage FR; Dijkstra PU; Manson WL; de Vries EG; Roodenburg JL
Br J Cancer; 2003 Apr; 88(7):1012-6. PubMed ID: 12671696
[TBL] [Abstract][Full Text] [Related]
18. Skin/mucosa avoidance radiotherapy (SMART) versus conventional volumetric arc-based radiotherapy (VMAT) for the treatment of head and neck cancer: Dosimetric feasibility study.
Anderson C; MacDonald RL; Wilke D
J Appl Clin Med Phys; 2023 Aug; 24(8):e14000. PubMed ID: 37139991
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
